{"id":"W4253648635","doi":"10.1182/blood.v104.11.641.641","title":"CHIR258, a Novel Multi-Targeted Tyrosine Kinase Inhibitor, for the Treatment of t(4;14) Multiple Myeloma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Fibroblast growth factor receptor 3; Tyrosine kinase; Cancer research; Biology; Tyrosine-kinase inhibitor; Receptor tyrosine kinase; Chromosomal translocation; Fibroblast growth factor receptor; Multiple myeloma; Fibroblast growth factor; Cell culture; Molecular biology; Receptor; Kinase; Signal transduction; Cell biology; Immunology; Cancer; Biochemistry; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001010458,0.0004521447,0.0002720856,0.0005390345,0.0002095322,0.0001882905,0.0002857159,0.0003058792,0.001639402],"category_scores_gemma":[0.00005004913,0.0001178257,0.0002062889,0.0002618076,0.0001596257,0.0001303971,0.0001311814,0.0005658153,0.000547213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004161304,"about_ca_system_score_gemma":0.0003473425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000902472,"about_ca_topic_score_gemma":0.004181525,"domain_scores_codex":[0.9999638,0.000004991114,0.000002512611,0.000007352621,0.00001175336,0.000009570805],"domain_scores_gemma":[0.9999751,0.00000289304,0.000005912235,0.000001170894,0.000003104706,0.00001178429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002180175,0.001480121,0.00252425,0.0006363624,0.00007178654,0.001686419,0.00006242362,0.001649806,0.8543405,0.0008405983,0.007510774,0.1270167],"study_design_scores_gemma":[0.007621375,0.04296809,0.05222079,0.0002941832,0.0005215029,0.01466103,0.0001053936,0.007373288,0.7614442,0.0005081985,0.1121533,0.0001286773],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.943819,0.03023832,0.003534452,0.001577933,0.0003206572,0.0008707637,0.001921121,0.0004963566,0.01722126],"genre_scores_gemma":[0.959181,0.0189214,0.005359668,0.0006904238,0.00007883913,0.0003962317,0.003570232,0.00002066661,0.01178171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001639402,"threshold_uncertainty_score":0.005484343,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04047147652059239,"score_gpt":0.3035838897335806,"score_spread":0.2631124132129882,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}